Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 41-47, January 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebert, P. S.
Right arrow Articles by Chirigos, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebert, P. S.
Right arrow Articles by Chirigos, M. A.

Erythropoietic Responses of Mice to Infection with Rauscher Leukemia Virus1

Paul S. Ebert, Nancy E. Maestri and Michael A. Chirigos

Viral Biology Branch, National Cancer Institute, Bethesda, Maryland 20014

The prelymphoid leukemic phase of Rauscher leukemia virus (RLV) infection is characterized by erythroblastosis, reticulocytosis, splenomegaly, and anemia. Reticulocyte counts increased, and RBC, hematocrit, and hemoglobin levels decreased progressively until the 29th day after RLV inoculation. Splenic and hepatic {delta}-aminolevulinic acid synthetase activity, on a per g tissue basis, decreased compared with normal activity. However, since the spleen increased to 25 times its normal size, the net {delta}-aminolevulinic acid synthetase activity increased 1340% compared with normal spleen activity. In contrast, mice treated with phenylhydrazine, a drug which causes hemolytic anemia, showed a threefold normal increase in the specific activity of splenic {delta}-aminolevulinic acid synthetase but showed only a small increase in spleen size. These findings suggest that the RLV-induced anemia does not trigger the same erythropoietic response as does the drug-induced anemia.

Since erythropoietin (ESF) mediates RBC production, the role of this hormone in RLV infection was examined. Low levels of ESF were found in plasma from mice infected with RLV for 7 to 35 days, but the ESF activity was inappropriate for the extent of the anemia. Bleeding of RLV-infected mice to stimulate ESF production did not elicit any response. The possibility that RLV, like the Friend virus, may stimulate erythropoiesis in the absence of ESF production is discussed.

1 Portions of this work have been presented (8).

Received 1/25/71. Accepted 8/23/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.